Nycrist Pharmatech Limited

新闻中心 / News More

Learn more

投资案例 / case

XRPD

2013 - 11 - 29

XPRD

XRPD

2013 - 11 - 29

XRPD

DSC

2013 - 11 - 29

DSC

2013 - 11 - 29

TGA

2013 - 11 - 29

TGA

XRPD

2013 - 11 - 29

XRPD

polarized light microscopy

2016 - 03 - 23

polarized light microscopy

Raman

2016 - 03 - 18

Raman

Crystal 16

2016 - 03 - 18

Crystal 16

2016 - 03 - 18

The corner of lab

2016 - 03 - 18

The Lab

2016 - 03 - 18

The corner of lab

more >>

Nycrist Pharmatech Limited is an innovation-orientated contract research organization founded by a group of highly energetic and qualified scientists dedicated to integrating front-line technologies into innovative early stage drug development.

More than 40 % of newly discovered drugs have little or no water solubility, and over 90% of drugs approved since 1995 have poor solubility, poor permeability, or both. These molecules present unique development challenges but also potential successes. Nycrist was established to provide you support in developing effective solutions for poorly soluble compounds. Our extensive collaboration and consultation experience with international pharmaceutical companies allow us to offer top quality solid state packages ranging from solid form screening, excipients selection to further processing and formulation development, as well as a unique PAT approach.
Clients and Solid State are at the heart of our operation. We love what we do, and we enjoy sharing ideas and skills with our clients. We design and select solid state approaches for your APIs based on the unique physico-chemical properties of each model compound and the physical chemistry mechanism of its optimal delivery systems. A special focus will also be placed on introducing innovative and integrated strategies to ensure effective solid form screen and deeper understanding of your API to support your drug development processes.

师资力量 / Teacher More>>

师资队伍

More>>

新闻动态 / News 查看更多>>

新阳唯康获邀参加第五届中国药物制剂大会

2013 - 12 - 11

点击次数: 39

2015年9月25 – 27 日，新阳唯康获邀参加第五届中国药物制剂大会（浙江大学体育馆）。新阳唯康科技有限公司的技术负责人田芳博士将展示近年来在药物固态研发领域的新进展，以及主要的发展方向。田芳博士也将与国内外药物研发人员深入交流新阳唯康在固态分析技术如拉曼光谱对于药物的剂型设计，特别是溶液制剂方面的生产质量检测与在线固态控制方面的新进展。该技术为设计高效、简单稳定的溶液剂型提供了崭新的研发前景。

[ ]

奥克兰大学frederique vanholsbeeck 博士来我司参观

发布时间： 2016 - 10 - 18

点击次数： 35

Frederique vanholsbeeck博士是奥克兰大学物理系高级讲师，同时也是享誉国内外食品安全方面最具有影响力的人物之一，还是中国与新西兰食品安全和医药方面重要的链接纽带。2016年10月17日上午，新西兰奥克兰大学frederique vanholsbeeck 博士在我司CEO田芳博士的陪同下，对公司进行全面参观，并进行医药技术探讨和交流，共同商讨深化合作事宜，共谋发展共赢大计。参观期间，实验室各科研人员向frederique vanholsbeeck 博士讲解并展示了我司专业的医药研发技术以及各项先进的仪器设备。随后田芳博士向frederique vanholsbeeck 博士介绍了公司发展、人才引进、平台建设、配套服务等方面的情况。通过沟通交流，frederique vanholsbeeck 博士表示，非常看好我司创业创新的环境和专业条件，将会进一步深化我们的合作，并提高双方合作效率和次数。参观最后，全体工作人员与frederique vanholsbeeck 博士进行合照，留下此次愉快的交流纪念！

[Detail]

FACILTIES / News 查看更多>>

Clients / Clients

XRPD

DSC

DSC

TGA

XRPD

polarized light microscopy

Raman

Crystal 16